Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINIMISE STEMI
2013-001069-18Phase 3Completed
- Sponsor
- University College London
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of spironolactone in myocardial infarction (MI) (2 arms), sponsored by University College London. Started Jun 2013; status: completed.
02
Drugs
spironolactone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2013-001069-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001069-18.